Alnylam Pharmaceuticals I... (ALNY)
Alnylam Pharmaceuticals Max Pain By Strike
ALNY trades at $467.55, 33.6% above the near-term max pain of $350 expiring Sep 19, 2025 (28 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($230-$450), signaling increased put positioning or downside protection. Key magnetic zone at 290 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Alnylam Pharmaceuticals Max Pain By Expiry
Max pain for ALNY shows a downward trend from 450 to 230, indicating bearish sentiment or hedging activity. The 64% spread signals divergent expectations across timeframes. Most levels below 467.55 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
Expiration Date | Max Pain | Max Pain vs Current Price |
---|---|---|
Sep 19, 2025 | 350 | -117.55 (-25.14%) |
Oct 17, 2025 | 440 | -27.55 (-5.89%) |
Dec 19, 2025 | 290 | -177.55 (-37.97%) |
Jan 16, 2026 | 300 | -167.55 (-35.84%) |
Mar 20, 2026 | 400 | -67.55 (-14.45%) |
Jun 18, 2026 | 450 | -17.55 (-3.75%) |
Jul 17, 2026 | 290 | -177.55 (-37.97%) |
Jan 15, 2027 | 230 | -237.55 (-50.81%) |